Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Dec;69(12):1769-75.
doi: 10.1021/np060428x.

Cytotoxic flavaglines and bisamides from Aglaia edulis

Affiliations

Cytotoxic flavaglines and bisamides from Aglaia edulis

Soyoung Kim et al. J Nat Prod. 2006 Dec.

Erratum in

  • J Nat Prod. 2007 Apr;70(4):714

Abstract

Two new cyclopenta[b]benzofurans, aglaroxin A 1-O-acetate (2) and 3'-methoxyaglaroxin A 1-O-acetate (3), a new benzo[b]oxepine, 19,20-dehydroedulisone A (4), and five new cyclopenta[bc]benzopyrans, edulirin A (5), edulirin A 10-O-acetate (6), 19,20-dehydroedulirin A (7), isoedulirin A (8), and edulirin B (9), were isolated from the bark of Aglaia edulis, along with one known cyclopenta[b]benzofuran, aglaroxin A (1). Additionally, four new amides, aglamides A-D (10-13), as well as three known compounds, aglalactone, scopoletin, and 5-hydroxy-3,6,7,4'-tetramethoxyflavone, were isolated from the leaves and/or twigs of this species. The structures of the new compounds (2-13) were elucidated by interpretation of their spectroscopic data. All isolates obtained in this study were evaluated for cytotoxicity against both several human cancer cell lines (Lu1, LNCaP, and MCF-7) and a nontumorigenic (HUVEC) cell line. Among these isolates, the cyclopenta[b]benzofurans (1-3) exhibited potent in vitro cytotoxic activity (ED50 range 0.001 to 0.8 microg/mL). Aglaroxin A 1-O-acetate (2) was further evaluated in the in vivo P388 lymphocytic leukemia model, by intraperitoneal injection, but found to be inactive in this model.

PubMed Disclaimer

Figures

Figure 1
Figure 1

Similar articles

Cited by

References

    1. Proksch P, Edrada R, Ebel R, Bohnenstengel FI, Nugroho BW. Curr Org Chem. 2001;5:923–938.
    1. Kim S, Salim AA, Swanson SM, Kinghorn AD. Anti-cancer Agents Med Chem. 2006;6:319–345. - PubMed
    1. Brader G, Vajrodaya S, Greger H, Bacher M, Kalchhauser H, Hofer O. J Nat Prod. 1998;61:1482–1490. - PubMed
    1. Nugroho BW, Edrada RA, Wray V, Witte L, Bringmann G, Gehling M, Proksch P. Phytochemistry. 1999;51:367–376.
    1. Bacher M, Hofer O, Brader G, Vajrodaya S, Greger H. Phytochemistry. 1999;52:253–263.

Publication types

MeSH terms